Carregant…
Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2
There is an urgent need for antiviral agents that treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We screened a library of 1900 clinically safe drugs against OC43, a human beta coronavirus that causes the common cold, and evaluated the top hits against SARS-CoV-2. Twent...
Autors principals: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Online Article Text |
Idioma: | English |
Publicat: |
American Association for the Advancement of Science
2021
|
Matèries: | |
Accés en línia: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809056/ https://www.ncbi.nlm.nih.gov/pubmed/34285133 http://dx.doi.org/10.1126/science.abg5827 |